Choriocarcinoma

For patient information, click here

Choriocarcinoma
ICD-10	C58
ICD-9	181
ICD-O:	9100-9101
DiseasesDB	2602
MeSH	D002822

WikiDoc Resources for Choriocarcinoma
Articles
Most recent articles on Choriocarcinoma Most cited articles on Choriocarcinoma Review articles on Choriocarcinoma Articles on Choriocarcinoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Choriocarcinoma Images of Choriocarcinoma Photos of Choriocarcinoma Podcasts & MP3s on Choriocarcinoma Videos on Choriocarcinoma
Evidence Based Medicine
Cochrane Collaboration on Choriocarcinoma Bandolier on Choriocarcinoma TRIP on Choriocarcinoma
Clinical Trials
Ongoing Trials on Choriocarcinoma at Clinical Trials.gov Trial results on Choriocarcinoma Clinical Trials on Choriocarcinoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Choriocarcinoma NICE Guidance on Choriocarcinoma NHS PRODIGY Guidance FDA on Choriocarcinoma CDC on Choriocarcinoma
Books
Books on Choriocarcinoma
News
Choriocarcinoma in the news Be alerted to news on Choriocarcinoma News trends on Choriocarcinoma
Commentary
Blogs on Choriocarcinoma
Definitions
Definitions of Choriocarcinoma
Patient Resources / Community
Patient resources on Choriocarcinoma Discussion groups on Choriocarcinoma Patient Handouts on Choriocarcinoma Directions to Hospitals Treating Choriocarcinoma Risk calculators and risk factors for Choriocarcinoma
Healthcare Provider Resources
Symptoms of Choriocarcinoma Causes & Risk Factors for Choriocarcinoma Diagnostic studies for Choriocarcinoma Treatment of Choriocarcinoma
Continuing Medical Education (CME)
CME Programs on Choriocarcinoma
International
Choriocarcinoma en Espanol Choriocarcinoma en Francais
Business
Choriocarcinoma in the Marketplace Patents on Choriocarcinoma
Experimental / Informatics
List of terms related to Choriocarcinoma

Editor-in-Chief: Somal Khan, M.D.

Overview

Choriocarcinoma is a malignant and aggressive cancer of the placenta. It is characterized by early hematogenous spread to the lungs. It belongs to the far end of the spectrum of gestational trophoblastic diseases (GTD).

Classification of GTDs

Broadly, gestational trophoblastic diseases can be classified in the following:

1. Hydatidiform Mole

a. Complete Mole

b. Partial Mole

2. Invasive Mole

3. Choriocarcinoma

4. Placental site trophoblastic tumor

Etiology/Epidemiology

It is preceded by:

• Hydatidiform mole (50% of cases)
• Spontaneous abortion (20% of cases)
• Ectopic pregnancy (2% of cases)
• Normal term pregnancy (20-30% of cases)

Symptoms/Signs/Labs

• increased quantitative β-hCG levels
• vaginal bleeding
• shortness of breath
• hemoptysis (coughing up blood)
• chest pain
• chest X-ray shows multiple infiltrates of various shapes in both lungs
• presents in males as a testicular neoplasm

Pathology

On light microscopy, there is malignant trophoblastic proliferation without hydropic villi.

Treatment

Choriocarcinoma is one of the tumors that is most sensitive to chemotherapy. The cure rate, even for metastatic choriocarcinoma, is around 90-95%. Virtually everyone without metastases can be cured however metastatic disease to the kidneys and/or brain is usually fatal. Chemotherapy regimen include EMACO (etoposide, methotrexate, actinomycin D, cyclosphosphamide and oncovin).

Hysterectomy (surgical removal of the uterus) can also be offered to patients > 40 years of age or those desiring sterilization. It may be required for those with severe infection and uncontrolled bleeding.